e-learning
resources
Copenhagen 2005
Wednesday 21.09.2005
The injured lung: pathogenesis and interventions
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Potential role of cathepsin S in bleomycin-induced lung fibrosis
S. van den Brule, S. Godin, P. Misson, D. Lison, F. Huaux (Brussels, Belgium)
Source:
Annual Congress 2005 - The injured lung: pathogenesis and interventions
Session:
The injured lung: pathogenesis and interventions
Session type:
Poster Discussion
Number:
4642
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. van den Brule, S. Godin, P. Misson, D. Lison, F. Huaux (Brussels, Belgium). Potential role of cathepsin S in bleomycin-induced lung fibrosis. Eur Respir J 2005; 26: Suppl. 49, 4642
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Bronchoalveolar lavage (techniques, indications, results)
Altered microRNA profiles in the bronchoalveolar lavage fluid exosomes in asthma and COPD
Related content which might interest you:
A role for cathepsin S in the pathogenesis of cystic fibrosis lung disease?
Source: Annual Congress 2011 - Cell biology of lung disease
Year: 2011
Cathepsins in bleomycin-induced lung injury in rat
Source: Eur Respir J 2003; 22: 427-435
Year: 2003
The CDK4/6 inhibitor, palbociclib intensifies pulmonary inflammation in bleomycin-induced lung fibrosis
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Effects of elastase inhibitor on the epithelial cell apoptosis in bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology?
Year: 2008
HSP47siRNA targeting to myofibroblasts attenuates bleomycin-induced pulmonary fibrosis
Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside
Year: 2012
Targeting of cathepsin S reduces cystic fibrosis-like lung disease
Source: Eur Respir J, 53 (3) 1801523; 10.1183/13993003.01523-2018
Year: 2019
The role of cathepsin S in lung disease
Source: International Congress 2018 – Proteases: at the cutting edge of lung disease
Year: 2018
Neutrophil elastase is necessary for increases in active TGF-β in bleomycin-induced pulmonary fibrosis
Source: Eur Respir J 2001; 18: Suppl. 33, 199s
Year: 2001
The role of expression of TLR 4 in bleomycin-induced pulmonary fibrosis in mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Is cathepsin K a protective factor in the development of lung fibrosis?
Source: Eur Respir J 2002; 20: Suppl. 38, 479s
Year: 2002
17(R)-resolvin D1 attenuates bleomycin-induced lung fibrosis in mice
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
A role of Foxc2 gene in mice with bleomycin-induced pulmonary fibrosis
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Cathepsin S as a mediator of acute lung inflammation
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019
Enhancement of bleomycin-induced lung fibrosis in tenascin C-deficient mice
Source: Eur Respir J 2004; 24: Suppl. 48, 103s
Year: 2004
Evolution of biomechanical changes in a murine model of bleomycin-induced lung fibrosis: inflammation
versus
fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 396s
Year: 2006
Effect of nintedanib on silica-induced lung inflammation and fibrosis in mice
Source: Annual Congress 2012 - Interstitial lung disease: from bench to bedside
Year: 2012
Comparison of expression of napsin A and surfactant protein D in bleomycin-induced pulmonary fibrosis mouse model
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013
Time-course analysis of bleomycin-induced lung fibrosis in the rat
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
PD98059 attenuates the development of bleomycin-induced lung injury and fibrosis
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Surface enolase-1 mediated cell migration and lung fibrosis in bleomycin-induced mice
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept